Health Insurance Marketplace SM, 37593-37595 [2017-16979]
Download as PDF
asabaliauskas on DSKBBXCHB2PROD with NOTICES
Federal Register / Vol. 82, No. 154 / Friday, August 11, 2017 / Notices
Guidance/Legislation/Paperwork
ReductionActof1995/PRA-Listing.html.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. The term ‘‘collection of
information’’ is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and
includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires Federal agencies
to publish a 30-day notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension or
reinstatement of an existing collection
of information, before submitting the
collection to OMB for approval. No
comments were received in response to
the 60-day comment period. To comply
with this requirement, CMS is
publishing this notice that summarizes
the following proposed collection(s) of
information for public comment:
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Disclosure of
State Rating Requirements; Use: The
final rule ‘‘Patient Protection and
Affordable Care Act; Health Insurance
Market Rules; Rate Review’’ implements
sections 2701, 2702, and 2703 of the
Public Health Service Act (PHS Act), as
added and amended by the Affordable
Care Act, and sections 1302(e) and
1312(c) of the Affordable Care Act. The
rule directs that states submit to CMS
certain information about state rating
and risk pooling requirements for their
individual, small group, and large group
markets, as applicable. Specifically,
states will inform CMS of age rating
ratios that are narrower than 3:1 for
adults; tobacco use rating ratios that are
narrower than 1.5:1; a state-established
uniform age curve; geographic rating
areas; whether premiums in the small
and large group market are required to
be based on average enrollee amounts
(also known as composite premiums);
and, in states that do not permit any
rating variation based on age or tobacco
use, uniform family tier structures and
VerDate Sep<11>2014
17:18 Aug 10, 2017
Jkt 241001
corresponding multipliers. In addition,
states that elect to merge their
individual and small group market risk
pools into a combined pool will notify
CMS of such election. This information
will allow CMS to determine whether
state-specific rules apply or Federal
default rules apply. It will also support
the accuracy of the Federal risk
adjustment methodology. Form Number:
CMS–10454 (OMB control number:
0938–1258); Frequency: On Occasion;
Affected Public: State, Local, or Tribal
Governments, Private Sector; Number of
Respondents: 47; Total Annual
Responses: 47; Total Annual Hours:
2,239. (For policy questions regarding
this collection contact Russell Tipps at
301–492–4371.)
Dated: August 8, 2017.
William N. Parham, III,
Director, Paperwork Reduction Staff Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2017–17020 Filed 8–10–17; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–7046–N]
Health Insurance Marketplace SM,
Medicare, Medicaid, and Children’s
Health Insurance Programs; Meeting of
the Advisory Panel on Outreach and
Education (APOE), September 13, 2017
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
This notice announces the
next meeting of the Advisory Panel on
Outreach and Education (APOE) (the
Panel) in accordance with the Federal
Advisory Committee Act. The Panel
advises and makes recommendations to
the Secretary of the U.S. Department of
Health and Human Services (HHS) and
the Administrator of the Centers for
Medicare & Medicaid Services (CMS) on
opportunities to enhance the
effectiveness of consumer education
strategies concerning the Health
Insurance Marketplace SM, Medicare,
Medicaid, and the Children’s Health
Insurance Program (CHIP). This meeting
is open to the public.
DATES: Meeting Date: Wednesday,
September 13, 2017, 8:30 a.m. to 4:00
p.m. eastern daylight time (e.d.t).
Deadline for Meeting Registration,
Presentations, Special Accommodations
and Comments: Wednesday, August 30,
2017, 5:00 p.m. (e.d.t.).
SUMMARY:
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
37593
Meeting Location: U.S.
Department of Health & Human
Services, Hubert H. Humphrey Building,
200 Independence Avenue SW., Room
505A, Conference Room, Washington,
DC 20201.
Presentations and Written Comments:
Presentations and written comments
should be submitted to: Thomas Dudley,
Designated Federal Official (DFO),
Office of Communications, Centers for
Medicare & Medicaid Services, 7500
Security Boulevard, Mailstop S1–05–06,
Baltimore, MD 21244–1850 or via email
at Thomas.Dudley@cms.hhs.gov.
Registration: The meeting is open to
the public, but attendance is limited to
the space available. Persons wishing to
attend this meeting must register at the
Web site https://www.regonline.com/
apoesept2017meeting or by contacting
the DFO as listed in the FOR FURTHER
INFORMATION CONTACT section of this
notice, by the date listed in the DATES
section of this notice. Individuals
requiring sign language interpretation or
other special accommodations should
contact the DFO at the address listed in
the ADDRESSES section of this notice by
the date listed in the DATES section of
this notice.
FOR FURTHER INFORMATION CONTACT:
Thomas Dudley, Designated Federal
Official, Office of Communications,
CMS, 7500 Security Boulevard, Mail
Stop S1–05–06, Baltimore, MD 21244–
1850, 410–786–1442, email
Thomas.Dudley@cms.hhs.gov.
Additional information about the APOE
is available on the Internet at: https://
www.cms.gov/Regulations-andGuidance/Guidance/FACA/APOE.html.
Press inquiries are handled through the
CMS Press Office at (202) 690–6145.
SUPPLEMENTARY INFORMATION:
ADDRESSES:
I. Background
The Advisory Panel for Outreach and
Education (APOE) (the Panel) is
governed by the provisions of Federal
Advisory Committee Act (FACA) (Pub.
L. 92–463), as amended (5 U.S.C. App.
2), which sets forth standards for the
formation and use of federal advisory
committees. The Panel is authorized by
section 1114(f) of the Social Security
Act (42 U.S.C. 1314(f)) and section 222
of the Public Health Service Act (42
U.S.C. 217a).
The Secretary of the U.S. Department
of Health and Human Services (HHS)
(the Secretary) signed the charter
establishing the Citizen’s Advisory
Panel on Medicare Education 1 (the
1 We note that the Citizen’s Advisory Panel on
Medicare Education is also referred to as the
Advisory Panel on Medicare Education (65 FR
E:\FR\FM\11AUN1.SGM
Continued
11AUN1
asabaliauskas on DSKBBXCHB2PROD with NOTICES
37594
Federal Register / Vol. 82, No. 154 / Friday, August 11, 2017 / Notices
predecessor to the APOE) on January 21,
1999 (64 FR 7899, February 17, 1999) to
advise and make recommendations to
the Secretary and the Administrator of
the Centers for Medicare & Medicaid
Services (CMS) on the effective
implementation of national Medicare
education programs, including with
respect to the Medicare+Choice (M+C)
program added by the Balanced Budget
Act of 1997 (Pub. L. 105–33).
The Medicare Modernization Act of
2003 (MMA) (Pub. L. 108–173)
expanded the existing health plan
options and benefits available under the
M+C program and renamed it the
Medicare Advantage (MA) program. We
have had substantial responsibilities to
provide information to Medicare
beneficiaries about the range of health
plan options available and better tools
to evaluate these options. The
successful MA program implementation
required CMS to consider the views and
policy input from a variety of private
sector constituents and to develop a
broad range of public-private
partnerships.
In addition, Title I of the MMA
authorized the Secretary and the
Administrator of CMS (by delegation) to
establish the Medicare prescription drug
benefit. The drug benefit allows
beneficiaries to obtain qualified
prescription drug coverage. In order to
effectively administer the MA program
and the Medicare prescription drug
benefit, we have substantial
responsibilities to provide information
to Medicare beneficiaries about the
range of health plan options and
benefits available, and to develop better
tools to evaluate these plans and
benefits.
The Affordable Care Act (Patient
Protection and Affordable Care Act,
Public Law 111–148, and Health Care
and Education Reconciliation Act of
2010, Public Law 111–152) expanded
the availability of other options for
health care coverage and enacted a
number of changes to Medicare as well
as to Medicaid and the Children’s
Health Insurance Program (CHIP).
Qualified individuals and qualified
employers are now able to purchase
private health insurance coverage
through a competitive marketplace,
called an Affordable Insurance
Exchange (also called Health Insurance
MarketplaceSM,2 or MarketplaceSM). In
order to effectively implement and
administer these changes, we must
4617). The name was updated in the Second
Amended Charter approved on July 24, 2000.
2 Health Insurance MarketplaceSM and
MarketplaceSM are service marks of the U.S.
Department of Health & Human Services.
VerDate Sep<11>2014
17:18 Aug 10, 2017
Jkt 241001
provide information to consumers,
providers, and other stakeholders
through education and outreach
programs regarding how existing
programs will change and the expanded
range of health coverage options
available, including private health
insurance coverage through the
MarketplaceSM. The APOE allows us to
consider a broad range of views and
information from interested audiences
in connection with this effort and to
identify opportunities to enhance the
effectiveness of education strategies
concerning the Affordable Care Act.
The scope of this panel also includes
advising on issues pertaining to the
education of providers and stakeholders
with respect to the Affordable Care Act
and certain provisions of the Health
Information Technology for Economic
and Clinical Health (HITECH) Act
enacted as part of the American
Recovery and Reinvestment Act of 2009
(ARRA).
On January 21, 2011, the Panel’s
charter was renewed and the Panel was
renamed the Advisory Panel for
Outreach and Education. The Panel’s
charter was most recently renewed on
January 19, 2017, and will terminate on
January 19, 2019 unless renewed by
appropriate action.
Under the current charter, the APOE
will advise the Secretary and the
Administrator on optimal strategies for
the following:
• Developing and implementing
education and outreach programs for
individuals enrolled in, or eligible for,
Medicare, Medicaid, and the Children’s
Health Insurance Program (CHIP), or
coverage available through the Health
Insurance MarketplaceSM and other
CMS programs.
• Enhancing the federal government’s
effectiveness in informing Health
Insurance MarketplaceSM, Medicare,
Medicaid, and CHIP consumers, issuers,
providers, and stakeholders, through
education and outreach programs, on
issues regarding these programs,
including the appropriate use of publicprivate partnerships to leverage the
resources of the private sector in
educating beneficiaries, providers, and
stakeholders.
• Expanding outreach to vulnerable
and underserved communities,
including racial and ethnic minorities,
in the context of Health Insurance
MarketplaceSM, Medicare, Medicaid,
and CHIP education programs and other
CMS programs as designated.
• Assembling and sharing an
information base of ‘‘best practices’’ for
helping consumers evaluate health
coverage options.
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
• Building and leveraging existing
community infrastructures for
information, counseling, and assistance.
• Drawing the program link between
outreach and education, promoting
consumer understanding of health care
coverage choices, and facilitating
consumer selection/enrollment, which
in turn support the overarching goal of
improved access to quality care,
including prevention services,
envisioned under the Affordable Care
Act.
The current members of the Panel are:
Kellan Baker, Associate Director, Center
for American Progress; Robert Blancato,
President, Matz, Blancato & Associates;
Dale Blasier, Professor of Orthopaedic
Surgery, Department of Orthopaedics,
Arkansas Children’s Hospital; Deborah
Britt, Executive Director of Community
& Public Relations, Piedmont Fayette
Hospital; Deena Chisolm, Associate
Professor of Pediatrics & Public Health,
The Ohio State University, Nationwide
Children’s Hospital; Josephine DeLeon,
Director, Anti-Poverty Initiatives,
Catholic Charities of California; Robert
Espinoza, Vice President of Policy,
Paraprofessional Healthcare Institute;
Louise Scherer Knight, Director, The
Sidney Kimmel Comprehensive Cancer
Center at Johns Hopkins; Roanne
Osborne-Gaskin, M.D., Senior Medical
Director, MDWise, Inc.; Cathy Phan,
Outreach and Education Coordinator,
Asian American Health Coalition DBA
HOPE Clinic; Kamilah Pickett,
Litigation Support, Independent
Contractor; Brendan Riley, Outreach
and Enrollment Coordinator, NC
Community Health Center Association;
Alvia Siddiqi, Medicaid Managed Care
Community Network (MCCN) Medical
Director, Advocate Physician Partners,
Carla Smith, Executive Vice President,
Healthcare Information and
Management Systems Society (HIMSS);
Tobin Van Ostern, Vice President and
Co-Founder, Young Invincibles
Advisors; and Paula Villescaz, Senior
Consultant, Assembly Health
Committee, California State Legislature.
II. Provisions of This Notice
In accordance with section 10(a) of
the FACA, this notice announces a
meeting of the APOE. The agenda for
the September 13, 2017 meeting will
include the following:
• Welcome and listening session with
CMS leadership
• Recap of the previous (March 22,
2017) meeting
• Review CMS programs and initiatives
• Provide an opportunity for public
comment
• Summarize the meeting and review
recommendations and next steps
E:\FR\FM\11AUN1.SGM
11AUN1
Federal Register / Vol. 82, No. 154 / Friday, August 11, 2017 / Notices
Individuals or organizations that wish
to make a 5-minute oral presentation on
an agenda topic should submit a written
copy of the oral presentation to the DFO
at the address listed in the ADDRESSES
section of this notice by the date listed
in the DATES section of this notice. The
number of oral presentations may be
limited by the time available.
Individuals not wishing to make an oral
presentation may submit written
comments to the DFO at the address
listed in the ADDRESSES section of this
notice by the date listed in the DATES
section of this notice.
III. Security and Building
The meeting is open to the public, but
attendance is limited to the space
available. Persons wishing to attend this
meeting must register by contacting the
DFO at the address listed in the
ADDRESSES section of this notice or by
telephone at the number listed in the
FOR FURTHER INFORMATION CONTACT
asabaliauskas on DSKBBXCHB2PROD with NOTICES
section of this notice by the date
specified in the DATES section of this
notice.
Since this meeting will be held in a
Federal Government Building, the
Hubert H. Humphrey Building, Federal
security measures are applicable. In
planning your arrival time, we
recommend allowing additional time to
clear security. To gain access to the
building, participants will be required
to show a government-issued photo
identification (for example, driver’s
license or passport), and must be listed
on an approved security list before
persons are permitted entrance. Persons
not registered in advance will not be
permitted into the Hubert H. Humphrey
Building and will not be permitted to
attend the Panel meeting.
All persons entering the building
must pass through a metal detector. In
addition, all items brought to the Hubert
H. Humphrey Building, whether
personal or for the purpose of
presentation, are subject to inspection.
We cannot assume responsibility for
coordinating the receipt, transfer,
transport, storage, set-up, safety, or
timely arrival of any personal
belongings or items used for the purpose
of presentation.
Authority: 42 U.S.C. 217a, sec. 222 of the
Public Health Service Act, as amended; 42
U.S.C. 1314(f), sec. 1114(f) of the Social
Security Act; and Public Law 92–463, as
amended (5 U.S.C. App. 2).
Dated: August 2, 2017.
Seema Verma,
Administrator, Centers for Medicare &
Medicaid Services.
[FR Doc. 2017–16979 Filed 8–10–17; 8:45 am]
BILLING CODE 4120–01–P
VerDate Sep<11>2014
17:18 Aug 10, 2017
Jkt 241001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Macula
Degenerative Diseases
Date: August 23, 2017.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Nataliya Gordiyenko,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5202,
MSC 7846, Bethesda, MD 20892,
301.435.1265, gordiyenkon@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: August 7, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–16914 Filed 8–10–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Secretary; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Muscular Dystrophy
Coordinating Committee (MDCC).
The meeting will be open to the
public and accessible by live webcast.
Attendance is limited to space available.
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
37595
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Muscular Dystrophy
Coordinating Committee.
Type of meeting: Open Meeting.
Date: October 4, 2017.
Time: 8:30 a.m. to 4:30 p.m. *Eastern
Time*—Approximate end time.
Agenda: Agenda: The purpose of this
meeting is to bring together committee
members, representing government agencies,
patient advocacy groups, other voluntary
health organizations, and patients and their
families to update one another on progress
relevant to the Action Plan for the Muscular
Dystrophies and to coordinate activities and
discuss gaps and opportunities leading to
better understanding of the muscular
dystrophies, advances in treatments, and
improvements in patients’ and their families’
lives. Prior to the meeting, an agenda will be
posted to the MDCC meeting registration Web
site: https://meetings.ninds.nih.gov/
meetings/Oct42017/.
Registration: To register, please go to:
https://meetings.ninds.nih.gov/meetings/
Oct42017/.
Webcast Live: For those not able to attend
in person, this meeting will be webcast at:
https://videocast.nih.gov/.
Place: Neuroscience Center, Conference
Room C/D, 6001 Executive Boulevard,
Rockville, Maryland 20852.
Contact Person: Glen H. Nuckolls, Ph.D.,
Executive Secretary, Muscular Dystrophy
Coordinating Committee, National Institute
of Neurological Disorders and Stroke, NIH,
6001 Executive Boulevard, NSC 2203,
Bethesda, MD 20892, (301) 496–5745,
glen.nuckolls@ninds.nih.gov.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
All visitors must go through a security
check at the building entrance to receive a
visitor’s badge. A government issued photo
ID is required. Further information can be
found at the registration Web site: https://
meetings.ninds.nih.gov/meetings/Oct42017/.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
E:\FR\FM\11AUN1.SGM
11AUN1
Agencies
[Federal Register Volume 82, Number 154 (Friday, August 11, 2017)]
[Notices]
[Pages 37593-37595]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-16979]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-7046-N]
Health Insurance Marketplace[hairsp]\SM\, Medicare, Medicaid, and
Children's Health Insurance Programs; Meeting of the Advisory Panel on
Outreach and Education (APOE), September 13, 2017
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the next meeting of the Advisory Panel
on Outreach and Education (APOE) (the Panel) in accordance with the
Federal Advisory Committee Act. The Panel advises and makes
recommendations to the Secretary of the U.S. Department of Health and
Human Services (HHS) and the Administrator of the Centers for Medicare
& Medicaid Services (CMS) on opportunities to enhance the effectiveness
of consumer education strategies concerning the Health Insurance
Marketplace[hairsp]\SM\, Medicare, Medicaid, and the Children's Health
Insurance Program (CHIP). This meeting is open to the public.
DATES: Meeting Date: Wednesday, September 13, 2017, 8:30 a.m. to 4:00
p.m. eastern daylight time (e.d.t).
Deadline for Meeting Registration, Presentations, Special
Accommodations and Comments: Wednesday, August 30, 2017, 5:00 p.m.
(e.d.t.).
ADDRESSES: Meeting Location: U.S. Department of Health & Human
Services, Hubert H. Humphrey Building, 200 Independence Avenue SW.,
Room 505A, Conference Room, Washington, DC 20201.
Presentations and Written Comments: Presentations and written
comments should be submitted to: Thomas Dudley, Designated Federal
Official (DFO), Office of Communications, Centers for Medicare &
Medicaid Services, 7500 Security Boulevard, Mailstop S1-05-06,
Baltimore, MD 21244-1850 or via email at Thomas.Dudley@cms.hhs.gov.
Registration: The meeting is open to the public, but attendance is
limited to the space available. Persons wishing to attend this meeting
must register at the Web site https://www.regonline.com/apoesept2017meeting or by contacting the DFO as listed in the FOR
FURTHER INFORMATION CONTACT section of this notice, by the date listed
in the DATES section of this notice. Individuals requiring sign
language interpretation or other special accommodations should contact
the DFO at the address listed in the ADDRESSES section of this notice
by the date listed in the DATES section of this notice.
FOR FURTHER INFORMATION CONTACT: Thomas Dudley, Designated Federal
Official, Office of Communications, CMS, 7500 Security Boulevard, Mail
Stop S1-05-06, Baltimore, MD 21244-1850, 410-786-1442, email
Thomas.Dudley@cms.hhs.gov. Additional information about the APOE is
available on the Internet at: https://www.cms.gov/Regulations-and-Guidance/Guidance/FACA/APOE.html. Press inquiries are handled through
the CMS Press Office at (202) 690-6145.
SUPPLEMENTARY INFORMATION:
I. Background
The Advisory Panel for Outreach and Education (APOE) (the Panel) is
governed by the provisions of Federal Advisory Committee Act (FACA)
(Pub. L. 92-463), as amended (5 U.S.C. App. 2), which sets forth
standards for the formation and use of federal advisory committees. The
Panel is authorized by section 1114(f) of the Social Security Act (42
U.S.C. 1314(f)) and section 222 of the Public Health Service Act (42
U.S.C. 217a).
The Secretary of the U.S. Department of Health and Human Services
(HHS) (the Secretary) signed the charter establishing the Citizen's
Advisory Panel on Medicare Education \1\ (the
[[Page 37594]]
predecessor to the APOE) on January 21, 1999 (64 FR 7899, February 17,
1999) to advise and make recommendations to the Secretary and the
Administrator of the Centers for Medicare & Medicaid Services (CMS) on
the effective implementation of national Medicare education programs,
including with respect to the Medicare+Choice (M+C) program added by
the Balanced Budget Act of 1997 (Pub. L. 105-33).
---------------------------------------------------------------------------
\1\ We note that the Citizen's Advisory Panel on Medicare
Education is also referred to as the Advisory Panel on Medicare
Education (65 FR 4617). The name was updated in the Second Amended
Charter approved on July 24, 2000.
---------------------------------------------------------------------------
The Medicare Modernization Act of 2003 (MMA) (Pub. L. 108-173)
expanded the existing health plan options and benefits available under
the M+C program and renamed it the Medicare Advantage (MA) program. We
have had substantial responsibilities to provide information to
Medicare beneficiaries about the range of health plan options available
and better tools to evaluate these options. The successful MA program
implementation required CMS to consider the views and policy input from
a variety of private sector constituents and to develop a broad range
of public-private partnerships.
In addition, Title I of the MMA authorized the Secretary and the
Administrator of CMS (by delegation) to establish the Medicare
prescription drug benefit. The drug benefit allows beneficiaries to
obtain qualified prescription drug coverage. In order to effectively
administer the MA program and the Medicare prescription drug benefit,
we have substantial responsibilities to provide information to Medicare
beneficiaries about the range of health plan options and benefits
available, and to develop better tools to evaluate these plans and
benefits.
The Affordable Care Act (Patient Protection and Affordable Care
Act, Public Law 111-148, and Health Care and Education Reconciliation
Act of 2010, Public Law 111-152) expanded the availability of other
options for health care coverage and enacted a number of changes to
Medicare as well as to Medicaid and the Children's Health Insurance
Program (CHIP). Qualified individuals and qualified employers are now
able to purchase private health insurance coverage through a
competitive marketplace, called an Affordable Insurance Exchange (also
called Health Insurance Marketplace\SM\,\2\ or Marketplace\SM\). In
order to effectively implement and administer these changes, we must
provide information to consumers, providers, and other stakeholders
through education and outreach programs regarding how existing programs
will change and the expanded range of health coverage options
available, including private health insurance coverage through the
Marketplace\SM\. The APOE allows us to consider a broad range of views
and information from interested audiences in connection with this
effort and to identify opportunities to enhance the effectiveness of
education strategies concerning the Affordable Care Act.
---------------------------------------------------------------------------
\2\ Health Insurance Marketplace\SM\ and Marketplace\SM\ are
service marks of the U.S. Department of Health & Human Services.
---------------------------------------------------------------------------
The scope of this panel also includes advising on issues pertaining
to the education of providers and stakeholders with respect to the
Affordable Care Act and certain provisions of the Health Information
Technology for Economic and Clinical Health (HITECH) Act enacted as
part of the American Recovery and Reinvestment Act of 2009 (ARRA).
On January 21, 2011, the Panel's charter was renewed and the Panel
was renamed the Advisory Panel for Outreach and Education. The Panel's
charter was most recently renewed on January 19, 2017, and will
terminate on January 19, 2019 unless renewed by appropriate action.
Under the current charter, the APOE will advise the Secretary and
the Administrator on optimal strategies for the following:
Developing and implementing education and outreach
programs for individuals enrolled in, or eligible for, Medicare,
Medicaid, and the Children's Health Insurance Program (CHIP), or
coverage available through the Health Insurance Marketplace\SM\ and
other CMS programs.
Enhancing the federal government's effectiveness in
informing Health Insurance Marketplace\SM\, Medicare, Medicaid, and
CHIP consumers, issuers, providers, and stakeholders, through education
and outreach programs, on issues regarding these programs, including
the appropriate use of public-private partnerships to leverage the
resources of the private sector in educating beneficiaries, providers,
and stakeholders.
Expanding outreach to vulnerable and underserved
communities, including racial and ethnic minorities, in the context of
Health Insurance Marketplace\SM\, Medicare, Medicaid, and CHIP
education programs and other CMS programs as designated.
Assembling and sharing an information base of ``best
practices'' for helping consumers evaluate health coverage options.
Building and leveraging existing community infrastructures
for information, counseling, and assistance.
Drawing the program link between outreach and education,
promoting consumer understanding of health care coverage choices, and
facilitating consumer selection/enrollment, which in turn support the
overarching goal of improved access to quality care, including
prevention services, envisioned under the Affordable Care Act.
The current members of the Panel are: Kellan Baker, Associate
Director, Center for American Progress; Robert Blancato, President,
Matz, Blancato & Associates; Dale Blasier, Professor of Orthopaedic
Surgery, Department of Orthopaedics, Arkansas Children's Hospital;
Deborah Britt, Executive Director of Community & Public Relations,
Piedmont Fayette Hospital; Deena Chisolm, Associate Professor of
Pediatrics & Public Health, The Ohio State University, Nationwide
Children's Hospital; Josephine DeLeon, Director, Anti-Poverty
Initiatives, Catholic Charities of California; Robert Espinoza, Vice
President of Policy, Paraprofessional Healthcare Institute; Louise
Scherer Knight, Director, The Sidney Kimmel Comprehensive Cancer Center
at Johns Hopkins; Roanne Osborne-Gaskin, M.D., Senior Medical Director,
MDWise, Inc.; Cathy Phan, Outreach and Education Coordinator, Asian
American Health Coalition DBA HOPE Clinic; Kamilah Pickett, Litigation
Support, Independent Contractor; Brendan Riley, Outreach and Enrollment
Coordinator, NC Community Health Center Association; Alvia Siddiqi,
Medicaid Managed Care Community Network (MCCN) Medical Director,
Advocate Physician Partners, Carla Smith, Executive Vice President,
Healthcare Information and Management Systems Society (HIMSS); Tobin
Van Ostern, Vice President and Co-Founder, Young Invincibles Advisors;
and Paula Villescaz, Senior Consultant, Assembly Health Committee,
California State Legislature.
II. Provisions of This Notice
In accordance with section 10(a) of the FACA, this notice announces
a meeting of the APOE. The agenda for the September 13, 2017 meeting
will include the following:
Welcome and listening session with CMS leadership
Recap of the previous (March 22, 2017) meeting
Review CMS programs and initiatives
Provide an opportunity for public comment
Summarize the meeting and review recommendations and next
steps
[[Page 37595]]
Individuals or organizations that wish to make a 5-minute oral
presentation on an agenda topic should submit a written copy of the
oral presentation to the DFO at the address listed in the ADDRESSES
section of this notice by the date listed in the DATES section of this
notice. The number of oral presentations may be limited by the time
available. Individuals not wishing to make an oral presentation may
submit written comments to the DFO at the address listed in the
ADDRESSES section of this notice by the date listed in the DATES
section of this notice.
III. Security and Building
The meeting is open to the public, but attendance is limited to the
space available. Persons wishing to attend this meeting must register
by contacting the DFO at the address listed in the ADDRESSES section of
this notice or by telephone at the number listed in the FOR FURTHER
INFORMATION CONTACT section of this notice by the date specified in the
DATES section of this notice.
Since this meeting will be held in a Federal Government Building,
the Hubert H. Humphrey Building, Federal security measures are
applicable. In planning your arrival time, we recommend allowing
additional time to clear security. To gain access to the building,
participants will be required to show a government-issued photo
identification (for example, driver's license or passport), and must be
listed on an approved security list before persons are permitted
entrance. Persons not registered in advance will not be permitted into
the Hubert H. Humphrey Building and will not be permitted to attend the
Panel meeting.
All persons entering the building must pass through a metal
detector. In addition, all items brought to the Hubert H. Humphrey
Building, whether personal or for the purpose of presentation, are
subject to inspection. We cannot assume responsibility for coordinating
the receipt, transfer, transport, storage, set-up, safety, or timely
arrival of any personal belongings or items used for the purpose of
presentation.
Authority: 42 U.S.C. 217a, sec. 222 of the Public Health Service
Act, as amended; 42 U.S.C. 1314(f), sec. 1114(f) of the Social
Security Act; and Public Law 92-463, as amended (5 U.S.C. App. 2).
Dated: August 2, 2017.
Seema Verma,
Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. 2017-16979 Filed 8-10-17; 8:45 am]
BILLING CODE 4120-01-P